Trials / Recruiting
RecruitingNCT06395415
Development of a Mobile Health Intervention for Electronic Cigarette Use Among Young Adults
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 46 (estimated)
- Sponsor
- University of Chicago · Academic / Other
- Sex
- All
- Age
- 18 Years – 26 Years
- Healthy volunteers
- Accepted
Summary
Electronic Nicotine Delivery Systems (ENDS) use remains prevalent among young adults, and many have high interest in quitting, yet research on effective intervention is lacking. A mobile health (mHealth) intervention that translates effective smoking cessation materials and pharmacotherapy may be a promising avenue for intervention. The initial phase of the proposed study uses a pilot study to evaluate a novel mHealth intervention for young adult ENDS and dual product (ENDS and combustible cigarette) users.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | EQUIP | The intervention is delivered directly to participants' mobile phones using the Insight® platform, which allows for the implementation of assessments and interventions. Insight has been used in prior mHealth studies and allows for the delivery of tailored content based on parameters, such as intervention stage. The intervention has two stages: 1) Motivational enhancement (weeks 1-2) and 2) Skills and information (weeks 3-6). The first stage of messages will utilize personalized feedback and motivational interviewing prompts, while the second stage will provide health information on ENDS and skills, such as deep breathing. Content is tailored to motivation level (low/medium or high) and dual use status. |
| BEHAVIORAL | Standard Care | Those in the standard advice group will be given offered a sample of NRT, instruction on its use, and will be encouraged to use in conjunction with standard web-based resources on ENDS and cessation over the course of a ten minute walk-through with study staff. |
Timeline
- Start date
- 2025-04-25
- Primary completion
- 2026-03-01
- Completion
- 2026-08-01
- First posted
- 2024-05-02
- Last updated
- 2026-01-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06395415. Inclusion in this directory is not an endorsement.